HomeABVC • NASDAQ
add
ABVC Biopharma Inc
Previous close
$1.38
Day range
$1.22 - $1.43
Year range
$0.61 - $5.48
Market cap
32.31M USD
Avg Volume
58.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Simply Wall Street
18 minutes ago
MKS Instruments SBTi Approval Adds ESG Dimension To Valuation Debate
0.019%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | -795.95K | -40,585.76% |
Operating expense | 2.20M | 191.92% |
Net income | -3.56M | -387.02% |
Net profit margin | 447.63 | 101.20% |
Earnings per share | — | — |
EBITDA | -2.99M | -303.63% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 745.83K | 138.20% |
Total assets | 21.06M | 179.34% |
Total liabilities | 7.76M | 13.92% |
Total equity | 13.30M | — |
Shares outstanding | 24.71M | — |
Price to book | 3.00 | — |
Return on assets | -35.41% | — |
Return on capital | -44.34% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.56M | -387.02% |
Cash from operations | -1.42M | -102.10% |
Cash from investing | 730.35K | 59.89% |
Cash from financing | 1.15M | 242.30% |
Net change in cash | 473.07K | 403.58% |
Free cash flow | 1.86M | 561.50% |
About
Founded
2015
Website
Employees
18
